Telix Pharmaceuticals Limited Stock Nasdaq
Stocks
TLX
US87961M1053
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 10.55 USD | -1.59% |
|
-7.86% | +40.85% |
| 09-10 | ASX Biggest Losers | MT |
| 09-02 | ASX Biggest Gainers | MT |
| Market Cap | 5.15B 3.58B 3.18B 2.97B 2.7B 5.1B 345B 35.96B 13.95B 176B 13.45B 13.15B 566B | P/E 2026 * |
214x | P/E 2027 * | 914x |
|---|---|---|---|---|---|
| Enterprise Value | 5.66B 3.94B 3.5B 3.26B 2.97B 5.61B 379B 39.54B 15.34B 194B 14.78B 14.46B 622B | EV / Sales 2026 * |
4.09x | EV / Sales 2027 * | 3.57x |
| Free-Float |
84.2% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TLX | Delayed | |
CBOE
| TLX | Real-time | |
|
Deutsche Boerse AG
| Delayed | ||
|
Deutsche Boerse AG
| T3X0 | End-of-day quote |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | -1.59% | ||
| 1 week | -7.86% | ||
| Current month | -3.83% | ||
| 1 month | -7.86% | ||
| 3 months | -11.12% | ||
| 6 months | +15.55% | ||
| Current year | +40.85% |
| 1 week | 10.45 |  | 11.69 |
| 1 month | 10.45 | | 13.11 |
| Current year | 6.28 | | 13.11 |
| 1 year | 6.28 | | 13.11 |
| 3 years | 6.28 | | 30.36 |
| 5 years | 6.28 | | 30.36 |
| 10 years | 6.28 | | 30.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2017-01-02 | |
Darren Smith
DFI | Director of Finance/CFO | 61 | 2022-07-30 |
David Cade
CTO | Chief Tech/Sci/R&D Officer | 57 | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 2017-01-02 | |
Mark Nelson
CHM | Chairman | 66 | 2026-02-02 |
Jann Skinner
BRD | Director/Board Member | 68 | 2018-06-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.59% | -7.86% | - | - | 3.58B | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 57.39B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.64B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.29B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.5B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 28.53B | |
| +0.05% | -1.64% | -7.28% | -14.06% | 24.34B | |
| Average | -0.36% | -0.59% | +54.39% | +120.28% | 43.39B | |
| Weighted average by Cap. | +0.11% | -0.84% | +58.77% | +129.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.39B 963M 856M 798M 727M 1.37B 92.78B 9.67B 3.75B 47.34B 3.62B 3.54B 152B | 1.58B 1.1B 974M 908M 827M 1.56B 106B 11.01B 4.27B 53.87B 4.12B 4.03B 173B |
| Net income | 29.41M 20.45M 18.17M 16.94M 15.43M 29.12M 1.97B 205M 79.65M 1B 76.76M 75.1M 3.23B | 6.21M 4.32M 3.83M 3.58M 3.26M 6.14M 416M 43.32M 16.81M 212M 16.2M 15.85M 681M |
| Net Debt | 513M 357M 317M 295M 269M 508M 34.33B 3.58B 1.39B 17.52B 1.34B 1.31B 56.3B | 473M 329M 292M 272M 248M 468M 31.66B 3.3B 1.28B 16.16B 1.23B 1.21B 51.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | US$10.55 | -1.59% | 299,612 |
| 26-10-01 | US$10.72 | -2.28% | 201,808 |
| 26-09-30 | US$10.97 | -3.26% | 344,244 |
| 26-09-29 | US$11.34 | -2.41% | 428,307 |
| 26-09-28 | US$11.62 | +1.48% | 851,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
